Deals > Southern Germany

Baden-Württemb. Bayern

Find below deals from the Southhern German Federal States of Baden-Württemberg and Bayern (Bavaria). Listed are deals for this region as well as from organisations located there.

Total search results: 854 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9

Deal: Collaboration or Financing	Date
Cyprumed–MC Services: public relations, 202504 service existent MC Services is media contact	2025-04-15
Dotmatics–Siemens: investment, 202402– acquisition $5.1b of Dotmatics from Insight Partners ANNOUNCED	2025-04-02
Meliodays Medical–Capacura: investment, 202503 pre-seed financing round totalling >€800k incl lead investor Capacura GmbH	2025-03-20
Meliodays Medical–FS Life Science Investment: investment, 202503 pre-seed financing round totalling >€800k incl co-investor FS Life Science Investment	2025-03-20
Meliodays Medical–MC Services: public relations, 202503 service existent MC Services is media contact	2025-03-20
Meliodays Medical–OTHER: investment, 202503 pre-seed financing round totalling >€800k incl other early stage investors + business angels	2025-03-20
Meliodays Medical–SEVERAL: investment, 202503 pre-seed financing round >€800k led by Capacura	2025-03-20
Vantis–Angelini: investment, 202503 financing round Series A totalling €10m incl lead investor Angelini Ventures	2025-03-12
Vantis–B2Venture: investment, 202503 financing round Series A totalling €10m incl existing + co-investor b2venture	2025-03-12
Vantis–Bavaria (govt): investment, 202503 financing round Series A totalling €10m incl co-investor Bayern Kapital	2025-03-12
Vantis–Firstminute Capital: investment, 202503 financing round Series A totalling €10m incl existing + co-investor Firstminute	2025-03-12
Vantis–SEVERAL: investment, 202503 financing round Series A €10m led by Angelini Ventures	2025-03-12
Vantis–Twip Impact Ventures: investment, 202503 financing round Series A totalling €10m incl co-investor Twip Impact Ventures	2025-03-12
OmicScouts–Momentum Biotechnologies: investment, 202503 acquisition of OmicScouts GmbH by Momentum Biotechnologies	2025-03-05
Atrandi Biosciences–Vsquared Ventures: investment, 202502 financing round Series A totalling $25m incl co-investor Vsquared Ventures	2025-02-19
Bürkert Fluidic Control Systems–Green Elephant Biotech: cell culture technology, 202502 strategic partnership incl strategic investment by Bürkert	2025-02-13
Green Elephant Biotech–Bürkert Fluidic Control Systems: investment, 202502 strategic investment by Bürkert as part of strategic partnership	2025-02-13
Avelios Medical–SEVERAL: investment, 202502 financing round Series A €30m led by Sequoia Capital	2025-02-06
Akribion–Carma Fund: investment, 202502 seed financing round totalling €8m incl co-lead investor Carma Fund	2025-02-04
Akribion–Vetter: investment, 202502 seed financing round totalling €8m incl co-lead investor RV Invest	2025-02-04
Candor Bioscience–Medix Biochemica: investment, 202501 acquisition of Candor Bioscience GmbH by Medix Biochemica	2025-01-22
Zwisler Laboratorium–Cormica: investment, 202501 acquisition of Zwisler Laboratorium GmbH by Cormica	2025-01-20
ITM–JPMorgan Chase: investor conference, 202501 supply service ITM presents at JP Morgan Healthcare Conference 2025	2025-01-13
Alesta Therapeutics–Vetter: investment, 202501 financing round Series A totalling €65m incl co-investor RV Invest	2025-01-08
Univ Zurich–Bruker: NMR spectrometer, 202412 supply 1.2 GHz Ascend NMR spectrometer to Swiss High-field NMR Facility at UZH	2024-12-20
Carl Roth–Bio Inx: bioinks, 202411– distribution ww of entire portfolio of bioinks of Bio Inx by Carl Roth	2024-11-27
Eisbach Bio–Texas (govt): grant, 202411 CPRIT grant $4.75m to support Ph1/2 study of EIS-12656 at MD Anderson	2024-11-26
Kyan Health–Schwabe: investment, 202411 financing round Series A totalling $12.7m incl co-investor NaturalX Health Ventures	2024-11-26
Baccinex–Adragos Pharma: investment, 202411 acquisition €na of Baccinex by Adragos Pharma	2024-11-25
Bico–RAG: investment, 202411 acquisition €26m of Nanoscribe from Bico Group by LAB14 GmbH	2024-11-21
Invios–MC Services: public relations, 202410 service existent by MC Services	2024-11-13
Aignostics–Carma Fund: investment, 202410 financing round Series B totalling $34m incl existing + co-investor Carma Fund	2024-10-29
Aignostics–Strüngmann Group: investment, 202410 financing round Series B totalling $34m incl lead investor Athos	2024-10-29
Aignostics–Wellington Partners: investment, 202410 financing round Series B totalling $34m incl existing + co-investor Wellington Partners	2024-10-29
Kynos Therapeutics–Falk Pharma: investment, 202410 acquisition of Kyno Therapeutics Ltd by Dr Falk Pharma GmbH	2024-10-29
Somagenetix–MC Services: public relations, 202410 service existent by MC Services	2024-10-08
Dynamic Biosensors–Bruker: investment, 202410 acquisition €na of Dynamic Biosensors GmbH + integration in Bruker Biosensors business	2024-10-02
Erbe Elektromedizin–1BillionLives: quality management software, 202409 supply existent Erbe is customer of Flinn.ai	2024-09-30
Trials24–Subject Well: investment, 202409 acquisition of Trials24 by SubjectWell backed by PE firm WindRose Health	2024-09-17
Symphera–Bavaria (govt): investment, 202409 seed financing round totalling €2.4m incl co-investor HTGF	2024-09-16
Symphera–Carma Fund: investment, 202409 seed financing round totalling €2.4m incl co-investor Carma Fund	2024-09-16
Symphera–High-Tech Gründerfonds: investment, 202409 seed financing round totalling €2.4m incl lead investor HTGF	2024-09-16
Symphera–IRCAD: investment, 202409 seed financing round totalling €2.4m incl co-investor IRCAD Strasbourg	2024-09-16
Symphera–OTHER: investment, 202409 seed financing round totalling €2.4m incl expert business angels from the medical field	2024-09-16
Symphera–SEVERAL: investment, 202409 seed financing round €2.4m led by HTGF	2024-09-16
Symphera–Stern Stewart: investment, 202409 seed financing round totalling €2.4m incl co-investor Stern Stewart Ventures	2024-09-16
Symphera–TU Munich: investment, 202409 seed financing round totalling €2.4m incl co-investor UnternehmerTUM Funding for Innovators	2024-09-16
CPTx–Bavaria (govt): investment, 202409 financing round totalling $29m incl co-investor Bayern Kapital	2024-09-12
CPTx–BY Capital: investment, 202409 financing round totalling $29m incl co-lead investor BlueYard Capital	2024-09-12
CPTx–Germany (govt): investment, 202409 financing round totalling $29m incl co-lead investor SPRIND	2024-09-12
CPTx–Leblon Capital: investment, 202409 financing round totalling $29m incl co-investor Leblon Capital (Andrej Henkler)	2024-09-12
CPTx–PERSON: investment, 202409 financing round totalling $29m incl co-investor Marius Nacht Group	2024-09-12
CPTx–PERSON: investment, 202409 financing round totalling $29m incl several industry veterans incl Stefan Oschmann	2024-09-12
CPTx–SEVERAL: investment, 202409 financing round $29m led by BlueYard Capital + SPRIND	2024-09-12
Inflammatix–Think.Health: investment, 202409 financing round Series E totalling $57m incl co-lead investor Think.Health	2024-09-12
Bambusa Therapeutics–Salvia: investment, 202409 seed financing round totalling $15m incl founding + co-investor Salvia GmbH	2024-09-09
Alphalytik Pharmaservice–Certania: investment, 202409 acquisition of Alphalytik Pharmaservice GmbH by Certania	2024-09-04
Lucid Genomics–Caesar Ventures: investment, 202408 pre-seed financing round totalling €1.3m incl lead investor Caesar Ventures	2024-09-02
Aitiologic–Siemens: liquid biopsy technology, 202409c license excl to IP related to aitios platform initially developed by founder at S Healthineers	2024-09-01
Allogenetics–Carma Fund: investment, 202408 first financing round totalling €3.4m incl co-lead investor Carma Fund	2024-08-29
Irubis–SEVERAL: investment, 202408 financing round pre-Series A led by new investor BioProcess360 Partners	2024-08-29
PL BioScience–Better Ventures: investment, 202408 financing round Series A totalling €7.8m incl new investor Better Ventures	2024-08-08
Bruker–Novalix: drug discovery technology, 202408– strategic collab to enable new paradigms in drug discovery	2024-08-07
NEC–Asahi Glass: contract manufacturing, 202408– collab developm production techn + supply cancer vaccine NECVAX-NEO1 by AGC Biologics + NEC Bio Tx	2024-08-07
Leon-Nanodrugs–Albany Private Equity: investment, 202408 financing round Series D incl existing + co-investor Albany Private Equity Holindgs Pty Ltd	2024-08-06
Leon-Nanodrugs–Baden-Württemberg (govt): investment, 202408 financing round Series D incl new + lead investor LBBW Venture Capital	2024-08-06
Leon-Nanodrugs–CD-Venture: investment, 202408 financing round Series D incl existing + co-investor CD-Venture GmbH	2024-08-06
Leon-Nanodrugs–Eckenstein-Geigy-Stiftung: investment, 202408 financing round Series D incl existing + co-investor Eckenstein-Geigy-Stiftung	2024-08-06
Leon-Nanodrugs–SEVERAL: investment, 202408 financing round Series D led by new investor LBBW Venture Capital	2024-08-06
Leon-Nanodrugs–Signet Healthcare Partners: investment, 202408 financing round Series D incl existing + co-investor Signet Healthcare Partners	2024-08-06
Leon-Nanodrugs–TVM: investment, 202408 financing round Series D incl existing + co-investor TVM Life Science Innovation I LP	2024-08-06
Biomatter Designs–UVC Partners: investment, 202408 seed financing round totalling €6.5m co-led by UVC Partners	2024-08-05
Ono Pharmaceutical–Systasy Bioscience: drug target discovery, 202407– collab research fees + milestones to identify + validate targets in neurology	2024-07-31
Systasy Bioscience–MC Services: public relations, 202407 service existent by MC Services	2024-07-31
Deepc–Bertelsmann: investment, 202407 financing round Series A extension totalling €13m incl existing + co-lead investor Bertelsmann Investments	2024-07-25
Deepc–CSS (CH): investment, 202407 financing round Series A extension totalling €13m incl new + co-investor SwissHealth Ventures	2024-07-25
Deepc–SEVERAL: investment, 202407 financing round Series A extension €13m led by Sofinnova Partners + Bertelsmann Investments	2024-07-25
Deepc–Sofinnova: investment, 202407 financing round Series A extension totalling €13m incl existing + co-lead investor Sofinnova Partners	2024-07-25
Deepc–United Kingdom (govt): investment, 202407 financing round Series A extension totalling €13m incl new + co-investor KHP Ventures	2024-07-25
Deepc–Winning Mindset Ventures: investment, 202407 financing round Series A extension totalling €13m incl existing + co-investor Winning Mindset	2024-07-25
SK Group–Full-Life Technologies: radionuclide-drug conjugate, 202407– license ww excl up to $571.5m to FL-091 anti-NTSR1 to SK Biopharmaceuticals	2024-07-17
Catalym–Bioqube Ventures: investment, 202407 financing round Series D totalling $150m incl new + co-lead investor Bioqube Ventures	2024-07-16
Catalym–Brandon Capital: investment, 202407 financing round Series D totalling $150m incl existing + co-investor Brandon Capital	2024-07-16
Catalym–Canaan Partners: investment, 202407 financing round Series D totalling $150m incl new + co-lead investor Canaan Partners	2024-07-16
Catalym–Forbion: investment, 202407 financing round Series D totalling $150m incl existing + co-investor Forbion Growth Opportunities Fund	2024-07-16
Catalym–Gilde Investment: investment, 202407 financing round Series D totalling $150m incl new + co-investor Gilde Healthcare	2024-07-16
Catalym–Jeito Capital: investment, 202407 financing round Series D totalling $150m incl existing + co-investor Jeito Capital	2024-07-16
Catalym–Novartis: investment, 202407 financing round Series D totalling $150m incl existing + co-investor Novartis Venture Fund	2024-07-16
Catalym–Omega Funds: investment, 202407 financing round Series D totalling $150m incl new + co-investor Omega Funds	2024-07-16
Catalym–SEVERAL: investment, 202407 financing round Series D $150m led by Canaan Partners + Bioqube Ventures	2024-07-16
Catalym–Vesalius Biocapital: investment, 202407 financing round Series D totalling $150m incl existing + co-investor Vesalius	2024-07-16
Affluent Medical–MC Services: public relations, 202407 service existent MC Services Is Media Contact for Europe	2024-07-12
HepaRegenix–Boehringer: investment, 202407 financing round Series C totalling €15m incl existing + co-investor BIVF	2024-07-10
HepaRegenix–High-Tech Gründerfonds: investment, 202407 financing round Series C totalling €15m incl existing + co-investor HTGF	2024-07-10
HepaRegenix–Novo Group: investment, 202407 financing round Series C totalling €15m incl existing + co-investor Novo Holdings	2024-07-10
HepaRegenix–SEVERAL: investment, 202407 financing round Series C €15m led by Vesalius Biocapital IV	2024-07-10
HepaRegenix–Vesalius Biocapital: investment, 202407 financing round Series C totalling €15m incl lead investor Vesalius Biocapital IV	2024-07-10
SciRhom–Andera Partners: investment, 202407 financing round Series A totalling €63m incl co-lead investor Andera Partners	2024-07-09
SciRhom–Bavaria (govt): investment, 202407 financing round Series A totalling €63m incl new + co-investor Bayern Kapital	2024-07-09
SciRhom–Eurazeo: investment, 202407 financing round Series A totalling €63m incl co-lead investor Kurma Partners	2024-07-09

1 2 3 4 5 6 7 8 9

Picture Informa Connect BioProcess Intl Europe 2025 Hamburg Register 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)